STOK — Stoke Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Stoke Therapeutics Inc (STOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.04% (2025 Q3)
Avg. % of fund
1.69%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 770,289 -19,409 -2.5% 2.80% $24.4M $31.74
2025 Q3 UNCHANGED 789,698 — 0% 3.04% $18.6M $23.50
2025 Q2 ADDED 789,698 +95,710 +13.8% 1.55% $9.0M $11.35
2025 Q1 ADDED 693,988 +8,162 +1.2% 0.79% $4.6M $6.65
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    STOK price (monthly, adj. close)

Other funds also holding STOK

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 34.73% Redmile Group, LLC 3Y 7Y 9.43% Birchview Capital, LP 3Y 7Y 4.83% Opaleye Management Inc. 3Y 7Y 2.91% BVF INC/IL 3Y 7Y 2.42% Siren, L.L.C. 2.13% RTW INVESTMENTS, LP 3Y 7Y 1.76% Quantedge Capital Pte Ltd 3Y 1.32% Parkman Healthcare Partners LLC 3Y 1.3% HighVista Strategies LLC 3Y 7Y 0.94%
← Back to MPM BioImpact LLC Holdings